Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines

Effect of chloride driven copper redox cycling on the kinetics of Fe(II) oxidation in aqueous solutions at pH 6.5–8.0

(2015) Yingying Sun et al.   GEOCHIMICA ET COSMOCHIMICA ACTA

Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: Mechanism and kinetics

(2014) A. Ninh Pham et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Protective and toxic roles of dopamine in Parkinson's disease

(2014) Juan Segura-Aguilar et al.   JOURNAL OF NEUROCHEMISTRY

Inhibition of the Fe(III)-Catalyzed Dopamine Oxidation by ATP and Its Relevance to Oxidative Stress in Parkinson’s Disease

(2013) Dianlu Jiang et al.   ACS Chemical Neuroscience

The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia

(2013) Richard P. Allen et al.   AMERICAN JOURNAL OF HEMATOLOGY

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

(2013) David Devos et al.   ANTIOXIDANTS & REDOX SIGNALING

Complexity of dopamine metabolism

(2013) Johannes Meiser et al.   Cell Communication and Signaling

Multi-Copper Oxidases and Human Iron Metabolism

(2013) Ganna Vashchenko et al.   Nutrients

Prevention of iron- and copper-mediated DNA damage by catecholamine and amino acid neurotransmitters, l-DOPA, and curcumin: metal binding as a general antioxidant mechanism

(2012) Carla R. García et al.   DALTON TRANSACTIONS

Iron and Neurodegeneration: From Cellular Homeostasis to Disease

(2012) Liliana Batista-Nascimento et al.   Oxidative Medicine and Cellular Longevity

Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease

(2011) Daniela Berg   ARCHIVES OF NEUROLOGY

Profile of altered brain iron acquisition in restless legs syndrome

(2011) J. R. Connor et al.   BRAIN

Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T α-Synuclein

(2011) Katherine C. M. Chew et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The potential application of iron chelators for the treatment of neurodegenerative diseases

(2011) Robert C. Hider et al.   Metallomics

High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: Quantitative imaging and correlation with iron

(2011) Vijay Antharam et al.   NEUROIMAGE

Brain iron levels in attention-deficit/hyperactivity disorder: A pilot MRI study

(2011) Samuele Cortese et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Kinetics of iron oxidation upon polyphenol binding

(2010) Nathan R. Perron et al.   DALTON TRANSACTIONS

Electrode potentials of partially reduced oxygen species, from dioxygen to water

(2010) Willem H. Koppenol et al.   FREE RADICAL BIOLOGY AND MEDICINE

A Calorie-Restricted Diet Decreases Brain Iron Accumulation and Preserves Motor Performance in Old Rhesus Monkeys

(2010) E. K. Kastman et al.   JOURNAL OF NEUROSCIENCE

A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding

(2009) Nathan R. Perron et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Binding of α-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes

(2009) Yong Peng et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Global Kinetic Explorer: A new computer program for dynamic simulation and fitting of kinetic data

(2008) Kenneth A. Johnson et al.   ANALYTICAL BIOCHEMISTRY

Redox imbalance in Parkinson's disease

(2008) Shankar J. Chinta et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Superoxide-mediated Fe(II) formation from organically complexed Fe(III) in coastal waters

(2008) Manabu Fujii et al.   GEOCHIMICA ET COSMOCHIMICA ACTA

Predicting How Polyphenol Antioxidants Prevent DNA Damage by Binding to Iron

(2008) Nathan R. Perron et al.   INORGANIC CHEMISTRY

Midbrain iron content in early Parkinson disease: A potential biomarker of disease status

(2008) W. R. W. Martin et al.   NEUROLOGY